Johnson & Johnson Legend Biotech Corp Transaction History
Johnson & Johnson
- $293 Million
- Q4 2024
A detailed history of Johnson & Johnson transactions in Legend Biotech Corp stock. As of the latest transaction made, Johnson & Johnson holds 814,586 shares of LEGN stock, worth $27.6 Million. This represents 9.04% of its overall portfolio holdings.
Number of Shares
814,586
Previous 814,586
-0.0%
Holding current value
$27.6 Million
Previous $39.7 Million
33.22%
% of portfolio
9.04%
Previous 12.65%
Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
232Shares Held
84MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$255 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$231 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$203 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$194 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$194 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.68B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...